Qbiotix is a UK IP development company whose key expertise lies in analyzing the thermodynamic and biochemical interaction between proteins/nucleic acids and synthetic probe constructs. Qbiotix has developed multiple medical diagnostic technologies for assays designed to support patient’s diagnosis rapidly with high sensitivity and specificity on standard lab equipment. Some of these technologies in advanced trials detect and inform on the interaction between viruses, bacteria and genomic mutations. A number of trading companies are expected to be generated to license off the Qbiotix IP in fields including clinical microbiology, toxin detection and food, beverage, environment testing.
